1. Home
  2. XENE
  3. XENE News

Latest Xenon Pharmaceuticals Inc. (XENE) News on September 5, 2025

Did Higher-Than-Expected Losses Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative?
XENE

Simply Wall St.

12 days ago

Did Higher-Than-Expected Losses Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative?

An Intrinsic Calculation For Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Suggests It's 44% Undervalued
XENE

Simply Wall St.

15 days ago

An Intrinsic Calculation For Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Suggests It's 44% Undervalued

Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
XENE

GlobeNewswire

2 months ago

Xenon Announces Appointment of Darren Cline as Chief Commercial Officer

XENE

MT Newswires

3 months ago

RBC Raises Price Target on Xenon Pharmaceuticals to $57 From $55, Keeps Outperform, Speculative Risk

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?
XENE

Zacks

3 months ago

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?

Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
XENE

GlobeNewswire

3 months ago

Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
XENE

GlobeNewswire

3 months ago

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
XENE

GlobeNewswire

4 months ago

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference

Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday
XENE

Insider Monkey

4 months ago

Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday

Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus
XENE

Zacks

4 months ago

Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus

XENE

MT Newswires

4 months ago

RBC Adjusts Price Target on Xenon Pharmaceuticals to $55 From $58, Maintains Outperform Speculative Risk Rating

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ...
XENE

GuruFocus.com

4 months ago

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ...

XENE

MT Newswires

4 months ago

Xenon Pharmaceuticals Q1 Loss Widens; Shares Drop

XENE

Associated Press Finance

4 months ago

Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
XENE

GlobeNewswire

4 months ago

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Report Preview: What To Look For
XENE

GuruFocus.com

4 months ago

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Report Preview: What To Look For

XENE

MT Newswires

4 months ago

Chardan Initiates Xenon Pharmaceuticals at Buy With $55 Price Target

Xenon to Report Q1 2025 Financial Results on May 12, 2025
XENE

GlobeNewswire

4 months ago

Xenon to Report Q1 2025 Financial Results on May 12, 2025

Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High?
XENE

Zacks

4 months ago

Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High?

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
XENE

GlobeNewswire

4 months ago

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
XENE

GlobeNewswire

5 months ago

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

Xenon to Present at Stifel 2025 Virtual CNS Forum
XENE

GlobeNewswire

6 months ago

Xenon to Present at Stifel 2025 Virtual CNS Forum

XENE

MT Newswires

6 months ago

RBC Capital Adjusts Xenon Pharmaceuticals Price Target to $58 From $56, Maintains Outperform - Speculative Risk Rating

Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus
XENE

Zacks

6 months ago

Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus

XENE

MT Newswires

6 months ago

Wedbush Adjusts Price Target on Xenon Pharmaceuticals to $42 From $43, Maintains Outperform Rating

XENE

MT Newswires

6 months ago

Deutsche Bank Adjusts Xenon Pharmaceuticals Price Target to $60 From $67, Maintains Buy Rating

Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...
XENE

GuruFocus.com

6 months ago

Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...

XENE

MT Newswires

6 months ago

Xenon Pharmaceuticals Q4 Net Loss Widens

XENE

Associated Press Finance

6 months ago

Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
XENE

GlobeNewswire

6 months ago

Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update

What To Expect From Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings
XENE

GuruFocus.com

6 months ago

What To Expect From Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings

Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
XENE

GlobeNewswire

6 months ago

Xenon to Present at the 45th Annual TD Cowen Healthcare Conference

Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
XENE

GlobeNewswire

7 months ago

Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025

XENE

MT Newswires

7 months ago

Deutsche Bank Initiates Coverage on Xenon Pharmaceuticals With Buy Rating, $67 Price Target

We're Not Very Worried About Xenon Pharmaceuticals' (NASDAQ:XENE) Cash Burn Rate
XENE

Simply Wall St.

7 months ago

We're Not Very Worried About Xenon Pharmaceuticals' (NASDAQ:XENE) Cash Burn Rate

XENE

MT Newswires

7 months ago

Xenon Pharmaceuticals Insider Sold Shares Worth $2,213,997, According to a Recent SEC Filing

XENE

MT Newswires

7 months ago

Wedbush Cuts Price Target on Xenon Pharmaceuticals to $43 From $46, Keeps Outperform Rating

Xenon Outlines Key Corporate Milestone Opportunities for 2025
XENE

GlobeNewswire

8 months ago

Xenon Outlines Key Corporate Milestone Opportunities for 2025

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
XENE

GlobeNewswire

8 months ago

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?
XENE

Zacks

9 months ago

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
XENE

GlobeNewswire

9 months ago

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
XENE

GlobeNewswire

9 months ago

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024

JPMorgan Selects These 2 Stocks as Must-Haves for 2025
XENE

TipRanks

9 months ago

JPMorgan Selects These 2 Stocks as Must-Haves for 2025

Xenon to Present at Upcoming Investor Conferences
XENE

GlobeNewswire

10 months ago

Xenon to Present at Upcoming Investor Conferences

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus
XENE

Zacks

10 months ago

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
XENE

GuruFocus.com

10 months ago

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...

XENE

MT Newswires

10 months ago

Xenon Pharmaceuticals Q3 Net Loss Widens

XENE

Associated Press Finance

10 months ago

Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Reports Q3 2024 Financial Results and Business Update
XENE

GlobeNewswire

10 months ago

Xenon Reports Q3 2024 Financial Results and Business Update

Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2024 Result
XENE

GuruFocus.com

10 months ago

Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2024 Result

Xenon to Report Q3 2024 Financial Results on November 12, 2024
XENE

GlobeNewswire

10 months ago

Xenon to Report Q3 2024 Financial Results on November 12, 2024

Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%
XENE

Zacks

a year ago

Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe
XENE

Zacks

a year ago

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

Xenon Pharmaceuticals Inc (XENE) Q2 2024 Earnings Call Highlights: Strategic Advances and ...
XENE

GuruFocus.com

a year ago

Xenon Pharmaceuticals Inc (XENE) Q2 2024 Earnings Call Highlights: Strategic Advances and ...

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
XENE

GlobeNewswire

a year ago

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

XENE

MT Newswires

a year ago

HC Wainwright Initiates Coverage on Xenon Pharmaceuticals With Buy Rating, $53 Price Target

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
XENE

GlobeNewswire

a year ago

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress

Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now
XENE

Insider Monkey

a year ago

Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely
XENE

Simply Wall St.

a year ago

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely

Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe
XENE

Zacks

a year ago

Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe

XENE

MT Newswires

a year ago

Xenon Pharmaceuticals Names Matthew Ronsheim Chief Operating Officer

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
XENE

GlobeNewswire

a year ago

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer

Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down
XENE

Zacks

a year ago

Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down

XENE

MT Newswires

a year ago

Wedbush Adjusts Xenon Pharmaceuticals' PT to $49 From $50, Keeps Outperform Rating

XENE

MT Newswires

a year ago

Xenon Pharmaceuticals Q2 Net Loss Widens

XENE

Associated Press Finance

a year ago

Xenon Pharmaceuticals: Q2 Earnings Snapshot

Xenon Reports Q2 2024 Financial Results and Business Update
XENE

GlobeNewswire

a year ago

Xenon Reports Q2 2024 Financial Results and Business Update

Xenon to Report Q2 2024 Financial Results on August 8, 2024
XENE

GlobeNewswire

a year ago

Xenon to Report Q2 2024 Financial Results on August 8, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Could Be 24% Below Their Intrinsic Value Estimate
XENE

Simply Wall St.

a year ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Could Be 24% Below Their Intrinsic Value Estimate

Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
XENE

Zacks

a year ago

Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag

Is Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50?
XENE

Insider Monkey

a year ago

Is Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50?

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO Compensation
XENE

Simply Wall St.

a year ago

Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO Compensation

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting

Hedge Funds are Racking Up Shares of This Healthcare Stock
XENE

Insider Monkey

a year ago

Hedge Funds are Racking Up Shares of This Healthcare Stock

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript
XENE

Insider Monkey

a year ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript

XENE

GuruFocus.com

a year ago

Xenon Pharmaceuticals Inc (XENE) Reports Increased Losses in Q1 2024, Despite Advancements in ...

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
XENE

Zacks

a year ago

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

XENE

MT Newswires

a year ago

Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating

XENE

MT Newswires

a year ago

Xenon Pharmaceuticals Q1 Net Loss Narrows

XENE

Associated Press Finance

a year ago

Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock
XENE

Zacks

a year ago

What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans
XENE

Simply Wall St.

a year ago

Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
XENE

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days

Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...
XENE

GuruFocus.com

a year ago

Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
XENE

GlobeNewswire

2 years ago

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript
XENE

Insider Monkey

2 years ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript

Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus
XENE

Zacks

2 years ago

Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus

XENE

GuruFocus.com

2 years ago

Xenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Results

XENE

Associated Press Finance

2 years ago

Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
XENE

GlobeNewswire

2 years ago

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
XENE

GlobeNewswire

2 years ago

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition
XENE

InvestorPlace

2 years ago

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition

Share on Social Networks: